How Lynparza (Olaparib) Treats Ovarian Cancer

FDA approved cancer treatment Lynparz (olaparib) treats various types of advanced ovarian cancers that contain a defective BRCA gene. In this video, medical oncologist Stephen Lemon MD discusses how this treatment works, as what types of side effects it may cause.

Lynparza is marketed by AstraZeneca Pharmaceuticals. Dr. Lemon is a medical oncologist who is not affiliated with AstraZeneca.

Click on the buttons below to view more videos that we have produced

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on email
Email